---
title: "Tarsus joins Stargardt race to market with $800m Alkeus takeover"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295254403.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-08-07T11:13:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295254403.md)
  - [en](https://longbridge.com/en/news/295254403.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295254403.md)
generator: "portal-rs"
---

# Tarsus joins Stargardt race to market with $800m Alkeus takeover

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [TARS.US](https://longbridge.com/en/quote/TARS.US.md)

## Related News & Research

- [Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care | TARS Stock News](https://longbridge.com/en/news/298040486.md)
- [Tarsus CMO Elizabeth Yeu disposes of common shares worth $787,879.86](https://longbridge.com/en/news/297955761.md)
- [OpenAI CFO Sarah Friar says ChatGPT's ads should be like 'if Google and Meta had a baby'](https://longbridge.com/en/news/298353501.md)
- [Aptar Pharma to support Aceso’s inhaled cystic fibrosis candidate’s advance](https://longbridge.com/en/news/298273759.md)
- [Peptide innovator says the drug class is due for a rethink](https://longbridge.com/en/news/297803292.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**